आईएसएसएन: 2329-9096
Emi Ohata, Eiji Nakatani*
With the aging of populations worldwide, hip fractures among older people emerge as a significant public health dilemma, substantially impairing mobility, diminishing life quality, and leading to increased mortality and healthcare expenditure. To address this, the Shizuoka Hip Fracture Prognostic Score (SHiPS) has been formulated to predict long-term mortality within Japan’s aging demographic. Analyzing data from 43,529 cases across 8.5 years, SHiPS assesses crucial factors, including sex, age, comorbidities, and ADL levels, categorizing mortality risk into four distinct levels, with ROC-AUC values surpassing 0.7, confirming its predictive accuracy. SHiPS notably uncovers marked sexbased disparities in mortality rates, with males exhibiting a heightened death risk over females, and delves into the varied impacts of diseases on these rates. Beyond guiding therapeutic and clinical management strategies and offering insights into both surgical and non-surgical options, SHiPS stresses the need for individualized treatment and optimal resource allocation in managing hip fractures. This review further details SHiPS, advocating for personalized care and highlighting the urgent requirement for continued research into treatment efficacies and sex-specific risk elements in elder hip fracture management.